Lavina Talukdar

Senior Vice President, Head Investor Relations at Moderna Therapeutics

Lavina Talukdar is an experienced financial professional currently serving as Senior Vice President and Head of Investor Relations at Moderna since April 2019. Prior to this role, Lavina held the position of Senior Portfolio Manager at the Abu Dhabi Investment Authority from March 2016 to February 2019. Earlier career highlights include serving as Partner and Senior Research Analyst at Lord, Abbett & Co. LLC from September 2007 to February 2016, and as a Senior Research Analyst at MFS Investment Management from 2004 to 2007, where Lavina managed healthcare investment portfolios. Additional experience includes the position of Principal at State Street Global Advisors, where research on global healthcare investments was a key responsibility, and as a Biotechnology Analyst at Fiduciary Trust Company International. Lavina Talukdar earned a Bachelor of Science in Business Administration and Management from Stony Brook University between 1992 and 1995.

Links

Previous companies

MFS Investment Management logo
Abu Dhabi Investment Authority logo
State Street Global Advisors logo
Lord Abbett logo